Today: 21 May 2026
Browse Category

Gold Prices 21 January 2026 - 26 January 2026

Buenaventura (BVN) stock jumps as gold tops $5,100 — what to watch next

Buenaventura (BVN) stock jumps as gold tops $5,100 — what to watch next

Buenaventura shares jumped 6.5% to $39.52 Monday after gold prices surged past $5,100 an ounce, setting a new record. Silver also hit an all-time high above $117 an ounce. Traders are watching the Federal Reserve’s January 27–28 meeting for signals on rates. Buenaventura’s San Gabriel project in Peru recently produced its first doré bar during commissioning.
26 January 2026
···
Gold price today: Gold hits $5,110 record as tariff threats and Fed drama jolt markets

Gold price today: Gold hits $5,110 record as tariff threats and Fed drama jolt markets

Gold soared above $5,100 an ounce Monday, hitting a new record as investors reacted to global tensions and tariff threats from President Trump. Spot silver also reached an all-time high at $113.61. Gold-backed funds and mining stocks rallied sharply. The dollar index slid to a four-year low, while traders awaited the Federal Reserve’s policy decision.
26 January 2026
···
Fed week starts: U.S. stock futures dip as Big Tech earnings loom and gold hits new record

Fed week starts: U.S. stock futures dip as Big Tech earnings loom and gold hits new record

S&P 500 futures slipped 0.1% early Monday as investors awaited the Federal Reserve’s policy decision and major tech earnings. Gold surged above $5,100 an ounce, rattling risk assets and lifting mining stocks. USA Rare Earth soared up to 62% premarket on reports of a planned Trump administration stake. Oil prices rose as winter storms disrupted U.S. production and geopolitical risks persisted.
26 January 2026
·············
UK stock market today: FTSE 100 steadies as gold tops $5,100 and Spire surges

UK stock market today: FTSE 100 steadies as gold tops $5,100 and Spire surges

FTSE 100 rose 0.05% to 10,148.03 by mid-morning Monday, lifted by metal miners as gold hit a record above $5,100 an ounce. Spire Healthcare jumped on takeover interest, while Costain advanced after a pension deal cleared the way for a £20 million share buyback. Sterling touched $1.3665, its highest since September. Banks drew focus ahead of earnings, with some expected to raise profit forecasts.
26 January 2026
····
CNMC Goldmine share price jumps nearly 12% as gold breaks $5,000 — what SGX traders are watching

CNMC Goldmine share price jumps nearly 12% as gold breaks $5,000 — what SGX traders are watching

CNMC Goldmine shares jumped 11.9% to S$1.41 in Singapore afternoon trading, hitting a new 52-week high as spot gold surged above $5,000 an ounce. Turnover in CNMC reached 17.28 million shares. Gold prices hit a record $5,092.71 before easing, driven by safe-haven demand and a weaker dollar. Traders are watching the upcoming U.S. Federal Reserve meeting for further signals.
26 January 2026
··
Evolution Mining share price jumps 5% as gold nears $5,000 — what to watch when the ASX reopens

Evolution Mining share price jumps 5% as gold nears $5,000 — what to watch when the ASX reopens

Evolution Mining shares closed at A$14.86 Friday, up 5.3%, with 7.43 million shares traded as gold prices neared record highs. The ASX will remain shut until Tuesday for the Australia Day holiday. Evolution’s quarterly report showed record mine cash flow but flagged a rain-related halt at Ernest Henry, which may trim copper and gold output. Investors await half-year results on Feb. 11.
25 January 2026
····
Northern Star share price: NST jumps 5% as gold hits records, but costs and broker nerves linger

Northern Star share price: NST jumps 5% as gold hits records, but costs and broker nerves linger

Northern Star Resources rose 5.4% to A$27.60 Friday as gold prices neared record highs, despite the company raising its FY26 cost forecast to A$2,600–A$2,800 per ounce. UBS downgraded the stock to Neutral on Jan. 22. The miner reported December quarter gold sales of 348,061 ounces at an AISC of A$2,937. Half-year results are due Feb. 12.
25 January 2026
····
Gold races toward $5,000 as Ray Dalio warns of ‘capital wars’ and dollar strain

Gold races toward $5,000 as Ray Dalio warns of ‘capital wars’ and dollar strain

Gold hit a record $4,993.02 an ounce Friday, silver topped $100, as investors sought safe havens amid geopolitical tensions and a weaker dollar. Ray Dalio warned at Davos that the old “rule-based” order is gone, raising the risk of “capital wars.” Asset managers promoted gold and bitcoin as hedges against inflation and currency debasement. The dollar index fell 1.65% this week after tariff threats over Greenland.
23 January 2026
Gold price today: Bullion snaps back toward $5,000 after Thursday dip — Delhi rates, MCX moves, and what’s driving it

Gold price today: Bullion snaps back toward $5,000 after Thursday dip — Delhi rates, MCX moves, and what’s driving it

Gold, silver, and platinum hit record highs in global trading Friday, with spot gold reaching $4,966.59 an ounce. Indian bullion prices tumbled Thursday as profit-taking set in, with Delhi 24K gold down 1.5% to ₹1,57,200 per 10 grams and silver off 4.3%. The rupee fell to a record low of 91.77 per U.S. dollar, raising the cost of gold imports. Traders cited shifting U.S. tariffs and dollar moves.
23 January 2026
··
Newmont stock price today: NEM cools after Tuesday pop as gold breaks $4,800

Newmont stock price today: NEM cools after Tuesday pop as gold breaks $4,800

Spot gold hit a record $4,887.82 an ounce Wednesday as geopolitical tensions rose over Trump’s Greenland bid. Newmont shares edged up 0.2% to $119.17 in afternoon trading after a volatile session. Agnico Eagle, Franco-Nevada, AngloGold Ashanti, and Gold Fields all slipped. Europe called an emergency summit for Thursday on the Greenland dispute.
21 January 2026
·······
1 2 3 4 5 6 … 9

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop